IDEAS home Printed from https://ideas.repec.org/p/ehl/lserod/55297.html
   My bibliography  Save this paper

Affordability of cancer care in the United Kingdom: is it time to introduce user charges?

Author

Listed:
  • Aggarwal, Ajay
  • Sullivan, Richard

Abstract

Context:- In high income countries the costs of delivering high quality equitable care are outstripping present budgets. This article reviews the affordability of cancer care in these countries with particular reference to the United Kingdom (U.K.). The question remains as to whether patients should contribute to their cancer treatment through the introduction of user charges, and whether such payments can be assimilated without undermining efficiency and equity of health care access. Methods:- In our review we analyse the drivers of increased cancer care utilisation, the current policies designed to control rising costs, and the potential impact of introducing patient user charges. The article also explores whether our understanding of behavioural economics could be used to create “nudge” policies that drive rational health care consumption. Findings:- The costs of cancer care in the U.K. are increasing at an unprecedented rate, driven by demographic changes, innovation (radiotherapy, drugs and imaging) and consumerism within health care. Budgets are tightly constrained and health technology assessments designed to ensure coverage of high value interventions have come under significant public and political scrutiny. User charges potentially provide a framework to “nudge” patients from low value care of limited effectiveness towards high value cost effective treatment, thereby increasing overall efficiency. However supply side controls are equally relevant with greater focus on physician test ordering, and improving the quality of doctor–patient communication, especially when discussing treatment options towards the end of life. Conclusions:- Fiscal sustainability of health care financing remains a key public policy concern. Attempts at ensuring coverage of cost effective treatments have been continuously challenged and without new policies, sustainability trade-offs may be necessary with potential rationing of high value treatments. User charges provide a potential means of sustaining spending proportional to the projected rise in number of cancer cases, whilst embracing technological innovations which could potentially improve outcomes.

Suggested Citation

  • Aggarwal, Ajay & Sullivan, Richard, 2014. "Affordability of cancer care in the United Kingdom: is it time to introduce user charges?," LSE Research Online Documents on Economics 55297, London School of Economics and Political Science, LSE Library.
  • Handle: RePEc:ehl:lserod:55297
    as

    Download full text from publisher

    File URL: http://eprints.lse.ac.uk/55297/
    File Function: Open access version.
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.
    2. Wind, Anke & Lobo, Mariana Fernandes & van Dijk, Joris & Lepage-Nefkens, Isabelle & Laranja-Pontes, José & da Conceição Gonçalves, Vítor & van Harten, Wim & Rocha-Gonçalves, Francisco Nuno, 2016. "Management and performance features of cancer centers in Europe: A fuzzy-set analysis," Journal of Business Research, Elsevier, vol. 69(11), pages 5507-5511.
    3. Navonil Deb & Abhinandan Dalal & Gopal Krishna Basak, 2020. "Finding Optimal Cancer Treatment using Markov Decision Process to Improve Overall Health and Quality of Life," Papers 2011.13960, arXiv.org.

    More about this item

    Keywords

    user charges; cancer care; nudge policies; affordability;
    All these keywords.

    JEL classification:

    • E6 - Macroeconomics and Monetary Economics - - Macroeconomic Policy, Macroeconomic Aspects of Public Finance, and General Outlook

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ehl:lserod:55297. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: LSERO Manager (email available below). General contact details of provider: https://edirc.repec.org/data/lsepsuk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.